506 related articles for article (PubMed ID: 24632932)
1. Implementation of a pharmacogenomics service in a community pharmacy.
Ferreri SP; Greco AJ; Michaels NM; O'Connor SK; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer MW
J Am Pharm Assoc (2003); 2014; 54(2):172-80. PubMed ID: 24632932
[TBL] [Abstract][Full Text] [Related]
2. Pharmacogenomics in a community pharmacy: ACT now.
Padgett L; O'Connor S; Roederer M; McLeod H; Ferreri S
J Am Pharm Assoc (2003); 2011; 51(2):189-93. PubMed ID: 21382809
[TBL] [Abstract][Full Text] [Related]
3. Community pharmacists' experience with pharmacogenetic testing.
Moaddeb J; Mills R; Haga SB
J Am Pharm Assoc (2003); 2015; 55(6):587-594. PubMed ID: 26409205
[TBL] [Abstract][Full Text] [Related]
4. Making pharmacogenetic testing a reality in a community pharmacy.
O'Connor SK; Ferreri SP; Michaels NM; Chater RW; Viera AJ; Faruki H; McLeod HL; Roederer M
J Am Pharm Assoc (2003); 2012; 52(6):e259-65. PubMed ID: 23229988
[TBL] [Abstract][Full Text] [Related]
5. Implementation of a pharmacist-led pharmacogenomics service for the Program of All-Inclusive Care for the Elderly (PHARM-GENOME-PACE).
Bain KT; Schwartz EJ; Knowlton OV; Knowlton CH; Turgeon J
J Am Pharm Assoc (2003); 2018; 58(3):281-289.e1. PubMed ID: 29602745
[TBL] [Abstract][Full Text] [Related]
6. Pediatric asthma medication therapy management through community pharmacy and primary care collaboration.
Bradley CL; Luder HR; Beck AF; Bowen R; Heaton PC; Kahn RS; Mansour M; Obszarski S; Frede SM
J Am Pharm Assoc (2003); 2016; 56(4):455-60. PubMed ID: 27245855
[TBL] [Abstract][Full Text] [Related]
7. Columbus Air Force Base medication profile intervention practice innovation.
Guill JV; Griffin LA; Goodwin TD
J Am Pharm Assoc (2003); 2008; 48(5):654-8. PubMed ID: 18826905
[TBL] [Abstract][Full Text] [Related]
8. The Innovative Canadian Pharmacogenomic Screening Initiative in Community Pharmacy (ICANPIC) study.
Papastergiou J; Tolios P; Li W; Li J
J Am Pharm Assoc (2003); 2017; 57(5):624-629. PubMed ID: 28689706
[TBL] [Abstract][Full Text] [Related]
9. Evaluating the economic impact of a targeted medication intervention program.
Rhodes SA; Reynolds AE; Marciniak MW; Ferreri SP
J Pharm Pract; 2013 Dec; 26(6):562-73. PubMed ID: 23804242
[TBL] [Abstract][Full Text] [Related]
10. Pharmacogenetics in the Community Pharmacy: Thienopyridine Selection Post-Coronary Artery Stent Placement.
Kisor DF; Bright DR; Conaway M; Bouts BA; Gerschutz GP
J Pharm Pract; 2014 Aug; 27(4):416-9. PubMed ID: 24532818
[TBL] [Abstract][Full Text] [Related]
11. Perceptions of patients on Medicare Part D medication therapy management services.
Truong HA; Layson-Wolf C; de Bittner MR; Owen JA; Haupt S
J Am Pharm Assoc (2003); 2009; 49(3):392-8. PubMed ID: 19443319
[TBL] [Abstract][Full Text] [Related]
12. Evaluation of the implementation process and outcomes of a professional pharmacy service in a community pharmacy setting. A case report.
Garcia-Cardenas V; Benrimoj SI; Ocampo CC; Goyenechea E; Martinez-Martinez F; Gastelurrutia MA
Res Social Adm Pharm; 2017; 13(3):614-627. PubMed ID: 27423785
[TBL] [Abstract][Full Text] [Related]
13. Impact of community pharmacist-performed post-discharge medication reviews in transitions of care.
Tetuan CE; Guthrie KD; Stoner SC; May JR; Hartwig DM; Liu Y
J Am Pharm Assoc (2003); 2018; 58(6):659-666. PubMed ID: 30056133
[TBL] [Abstract][Full Text] [Related]
14. Exploratory planning and implementation of a pilot pharmacogenetic program in a community pharmacy.
O'Connor SK; Ferreri SP; Michaels NM; Greco AJ; Viera AJ; Faruki H; McLeod HL; Roederer MW
Pharmacogenomics; 2012 Jun; 13(8):955-62. PubMed ID: 22676199
[TBL] [Abstract][Full Text] [Related]
15. Implementation of personalized medicine services in community pharmacies: perceptions of independent community pharmacists.
Alexander KM; Divine HS; Hanna CR; Gokun Y; Freeman PR
J Am Pharm Assoc (2003); 2014; 54(5):510-7, 5 p following 517. PubMed ID: 25148656
[TBL] [Abstract][Full Text] [Related]
16. Community pharmacists' educational needs for implementing clinical pharmacogenomic services.
Berenbrok LA; Hart KM; McGrath SH; Coley KC; Somma McGivney MA; Empey PE
J Am Pharm Assoc (2003); 2019; 59(4):539-544. PubMed ID: 31010787
[TBL] [Abstract][Full Text] [Related]
17. Financial Sustainability of an Oregon Rural Health, Primary Care, and Pharmacist-Run Comprehensive Medication Management Program Through Direct Medical Billing.
Hoover ND; Turner RB; Sampson J; Pye T; Hotan T
J Manag Care Spec Pharm; 2020 Jan; 26(1):30-34. PubMed ID: 31880232
[TBL] [Abstract][Full Text] [Related]
18. Opportunities for pharmacists to integrate pharmacogenomics into clinical practice.
Wang YT; Merl MY; Yang J; Zhu ZX; Li GH
Pharmacogenomics J; 2020 Apr; 20(2):169-178. PubMed ID: 31796890
[TBL] [Abstract][Full Text] [Related]
19. Forging a novel provider and payer partnership in Wisconsin to compensate pharmacists for quality-driven pharmacy and medication therapy management services.
Trapskin K; Johnson C; Cory P; Sorum S; Decker C
J Am Pharm Assoc (2003); 2009; 49(5):642-51. PubMed ID: 19748873
[TBL] [Abstract][Full Text] [Related]
20. Integrating pharmacogenomics into pharmacy practice via medication therapy management.
Reiss SM;
J Am Pharm Assoc (2003); 2011; 51(6):e64-74. PubMed ID: 22001957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
